DHEA Bioavailability Following Administration of Vaginal Suppositories in Post-Menopausal Women With Vaginal Atrophy

NCT00429806 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Vaginal Atrophy

Interventions

DRUG: DHEA
DRUG: Placebo

Sponsor

CHU de Quebec-Universite Laval